| Name | Lincare Inc |
|---|---|
| Organization Name | Lincare Inc |
| Location | 1555 Ashland City Rd, Clarksville, Tennessee 37040 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (931) 648-2331 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, "The evidence is clearly starting to show that it's much better to treat patients earlier, but from where will the money come?".
The early COVID-19 vaccination campaign in the U.S. prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study.
The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.
University of Manchester researchers have been awarded £1.6 million to study a group of genes identified as playing a key role in leukaemia.
› Verified 1 days ago
| NPI Number | 1811083033 |
| Organization Name | LINCARE INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 311 Landrum Pl Ste 500a&b, Clarksville, TN 37043 |
| Phone Number | 931-648-2331 |
News Archive
In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, "The evidence is clearly starting to show that it's much better to treat patients earlier, but from where will the money come?".
The early COVID-19 vaccination campaign in the U.S. prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study.
The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.
University of Manchester researchers have been awarded £1.6 million to study a group of genes identified as playing a key role in leukaemia.
› Verified 1 days ago
News Archive
In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, "The evidence is clearly starting to show that it's much better to treat patients earlier, but from where will the money come?".
The early COVID-19 vaccination campaign in the U.S. prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study.
The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.
University of Manchester researchers have been awarded £1.6 million to study a group of genes identified as playing a key role in leukaemia.
› Verified 1 days ago
A Step Ahead Orthotics And Prosthet Type: Prosthetic/Orthotic Supplier Location: 237 Dover Rd, Clarksville, Tennessee 37042 Phone: (615) 383-0048 | |
The Medicine Shoppe #0563 Type: Medicare Supplier Location: 1500 Madison St, Clarksville, Tennessee 37040 Phone: (931) 552-2552 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2292 Raleigh Ct, Clarksville, Tennessee 37043 Phone: (931) 648-9889 | |
Bulow Biotech Prosthetics Llc Type: Medicare Supplier Location: 705n 2nd St, Clarksville, Tennessee 37040 Phone: (931) 645-5741 | |
Clarksville Limb & Brace & Rehab In Type: Medicare Supplier Location: 980 Professional Park Dr, Clarksville, Tennessee 37040 Phone: (931) 648-2155 |